Knee Osteoarthritis
Conditions
Interventions
Tuina and drug combination group:Oral ericoxib tablets combined with Zhang's point therapy
Drug group:Oral ericoxib tablets
Sponsors
Yueyang Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for knee osteoarthritis; (2) Age 50-75 years old gender is not limited; (3) Duration of disease =1 week VAS score =7 points; (4) No other treatment has been received within 1 week before the visit; (5) Symptoms of acute exacerbation of pain such as knee swelling and pain; (6) The Kellgren-Lawrence grade of imaging should not exceed grade III; (7) Voluntarily participate in the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1) Allergic to non-steroidal anti-inflammatory drugs; 2) Patients with active gastrointestinal disease; (3) Patients with pain and limited activity around the knee joint caused by tuberculosis tumor or fracture; 4) Patients with local skin damage ulceration or skin diseases; 5) Patients with gouty rheumatic or rheumatoid knee arthritis; (6) Patients with serious primary diseases or mental diseases such as heart brain liver kidney hematopoietic system; 7) Patients with severe osteoporosis; 8) Patients with artificial joints.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate of adding etoricoxib tablets within 24 hours;Western Ontario and McMaster universities;CRP, ESR; | — |
Countries
China
Contacts
Public ContactSong Yang
Yueyang Hospital of Traditional Chinese Medicine
Outcome results
None listed